China Portable Medical Equipment Industry Report, 2013-2016
  • Apr./2014
  • Hard Copy
  • USD $1,900
  • Pages:78
  • Single User License
    (PDF Unprintable)       
  • USD $1,800
  • Code: ZLC-002
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,800
  • Hard Copy + Single User License
  • USD $2,100

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with market size growing at a CAGR of 28.3% in 2008-2013 to approximately RMB44.21 billion in 2013.

Allowing for the low penetration of portable medical devices (for example, market penetration of household glucometer is under 10% as opposed to the level of 90% in Europe, the United States and other developed countries), increasingly aging population, etc., China’s portable medical device market size is expected to remain above 25% growth rate in 2013-2016.

In China, portable medical devices are mainly used for home and clinical purposes, with market share of roughly 2:1 in 2013. Portable glucometer, electronic sphygmomanometer and electronic hearing aid as three hit products of China’s home-use portable medical device market accounted for a combined 93.6% in 2013.

Thus far, foreign-funded enterprises seize lion's share of China’s portable medical device market. Take household electronic sphygmomanometer and portable glucometer markets in 2013 for example, Japan-based OMRON accounted for more than 60% of China’s electronic sphygmomanometer market, followed by Andon Health, a domestic player whose market share was merely around 15%; America-based Johnson & Johnson and Switzerland-based Roche took 35% and 20% share of the Chinese portable glucometer market, separately, while the third and fourth-ranked domestic counterparts – Yicheng Bioelectronics and Sinocare only saw a combined share of 25%.

In China, clinical-use portable medical devices refer to portable multi-parameter monitor, portable diasonograph, portable electrocardiograph, interventional medical devices, portable fetal monitor, etc., of which, portable multi-parameter monitor and portable diasonograph occupy higher market share, respectively 32.5% and 25.0% of clinical-use portable medical device market in 2013.


The report highlights the followings:
20120114.gif? Status quo, related polices, market share, competition pattern, trends, etc. of portable medical device industry in China;
20120114.gif? Status quo, competition pattern, etc. of Chinese home-use and clinical-use portable medical device product segments;
20120114.gif? Operation, development in China and forecast of 4 international and 8 domestic portable medical device enterprises;

1. Overview of Portable Medical Device

2. China Portable Medical Device Market 
2.1 Status Quo 
2.2 Related Policies 
2.3 Market Size
2.4 Trends 
2.4.1 Increasing Market Share of Domestic Enterprises
2.4.2 Emergence of Wearable Medical Devices
2.4.3 More Convenient and Extending Medical Service 
2.4.4 Promising Market 

3. Home-Use Portable Medical Devices in China 
3.1 Product Structure 
3.2 Electronic Sphygmomanometer
3.3 Portable Glucometer
3.4 Digital Hearing Aid 

4. Clinical-Use Portable Medical Devices in China 
4.1 Product Structure
4.2 Portable Multi-Parameter Monitor
4.3 Portable Diasonograph
4.4 Interventional Medical Devices
4.4.1 Insulin Pump
4.4.2 Implantable Cardiac Pacemaker
4.4.3 Capsule Endoscopy
4.5 Portable Electrocardiograph
4.6 Intelligent Infusion Pump

5. Leading Overseas Enterprises 
5.1 Johnson & Johnson
5.1.1 Profile 
5.1.2 Operation 
5.1.3 Portable Medical Device 
5.1.4 Development in China 
5.2.1 Profile
5.2.2 Operation
5.2.3 Portable Medical Device
5.2.4 Development in China
5.3 A&D
5.3.1 Profile
5.3.2 Operation
5.3.3 Portable Medical Device
5.3.4 Development in China
5.4 Roche
5.4.1 Profile
5.4.2 Operation
5.4.3 Portable Medical Device
5.4.4 Development in China

6. Leading Chinese Enterprises 
6.1 Yu Yue Medical
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure 
6.1.4 Gross Margin 
6.1.5 R&D and Investment  
6.1.6 Prediction & Expectation 
6.2 Andon Health
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 Prediction & Expectation
6.3 Sinocare
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 R&D and Investment
6.3.6 Prediction & Expectation
6.4 Xiamen Comfort Science&Technology Group
6.4.1 Profile
6.4.2 Operation
6.4.3 Revenue Structure
6.4.4 Gross Margin
6.4.5 R&D and Investment
6.4.6 Portable Medical Device 
6.4.7 Prediction & Expectation
6.5 Guangdong Biolight Meditech
6.5.1 Profile
6.5.2 Operation
6.5.3 Revenue Structure
6.5.4 Gross Margin
6.5.5 R&D and Investment
6.5.6 Prediction & Expectation
6.6 Mindray Medical International Limited
6.6.1 Profile
6.6.2 Operation
6.6.3 Revenue Structure
6.6.4 Gross Margin
6.6.5 R&D and Investment
6.6.6 Portable Medical Device
6.6.7 Prediction & Expectation
6.7 Edan Instruments
6.7.1 Profile
6.7.2 Operation
6.7.3 Revenue Structure
6.7.4 Gross Margin
6.7.5 R&D
6.7.6 Prediction & Expectation
6.8 Yicheng Bioelectronics
6.8.1 Profile 

7. Conclusion & Outlook 
7.1 Forecasting for China Portable Medical Device Market Size
7.2 Operating Contrast
7.2.1 Revenue 
7.2.2 Net Margin 
7.2.3 Gross Margin
7.2.4 R&D Input
Classification of Portable Medical Devices 
Population Ages 65 and Above % of Total in China, 2004-2013 
China Portable Medical Device Market Size, 2008-2013 
China Home-use Portable Medical Device Product Structure, 2013 
Advantages and Disadvantages of Different Sphygmomanometers
Competition Pattern of China Electronic Sphygmomanometer Market, 2013 
Five Stages of Technology Development for Blood Glucose Meter
Competition Pattern of China Portable Glucometer Market, 2013
China Clinical-Use Portable Medical Device Market Share by Variety, 2013 
Portable Multi-parameter Monitor
Global Insulin Pump Market Size, 2012-2017E 
Implantation Amount of Cardiac Pacemakers in China, 2006-2013 
Revenue and Net Income of Johnson & Johnson, 2009-2013 
Gross Margin of Johnson & Johnson, 2009-2013 
Subsidiaries in China
Net Sales and Net Income of OMRON, 2009-2012 
OMRON’s Net Sales in China and % of Total Sales, 2009-2012 
OMRON’s Net Sales in China by Department, 2009-2012 
Sales and Net Income of A&D, 2009-2013 
Sales and Net Income of Roche, 2009-2013
Development History of Roche in China 
Revenue and Net Income of Yu Yue Medical, 2009-2013 
Revenue Structure of Yu Yue Medical by Product, 2009-2013 
Revenue Structure of Yu Yue Medicalby Region, 2009-2013
Gross Margin of Yu Yue Medical, 2009-2013 
Gross Margin of Yu Yue Medical by Product, 2009-2013 
Gross Margin of Yu Yue Medical by Region, 2009-2013
R&D Input and % of Total Revenue of Yu Yue Medical, 2010-2013 
Revenue and Net Income of Yu Yue Medical, 2012-2016E
Revenue and Net Income of Andon Health, 2009-2013 
Revenue Structure of Andon Health by Product, 2009-2013 
Revenue Structure of Andon Health by Region, 2009-2013
Gross Margin of Andon Health, 2009-2013 
Gross Margin of Andon Health by Product, 2009-2013 
Gross Margin of Andon Health by Region, 2009-2013
Revenue and Net Income of Andon Health, 2012-2016E 
Revenue and Net Income of Sinocare, 2009-2013 
Revenue Structure of Sinocare by Region, 2009-2013 
Revenue Structure of Sinocare by Product, 2009-2013
Gross Margin of Sinocare, 2009-2013 
Gross Margin of Sinocare by Region, 2009-2013
Gross Margin of Sinocare by Product, 2009-2013
R&D Input and % of Total Revenue of Sinocare, 2010-2013
Revenue and Net Income of Sinocare, 2012-2016E
Revenue and Net Income of Xiamen Comfort Science&Technology Group, 2009-2013 
Revenue Structure of Xiamen Comfort Science&Technology Group by Region, 2009-2013 
Revenue Structure of Xiamen Comfort Science&Technology Group by Product, 2009-2013
Gross Margin of Xiamen Comfort Science&Technology Group, 2009-2013 
Gross Margin of Xiamen Comfort Science&Technology Group by Region, 2009-2013 
R&D Input and % of Total Revenue of Xiamen Comfort Science&Technology Group, 2010-2013
Revenue and Net Income of Xiamen Comfort Science&Technology Group, 2012-2016E
Revenue and Net Income of Guangdong Biolight Meditech, 2009-2013 
Revenue Structure of Guangdong Biolight Meditech by Product, 2009-2013
Revenue Structure of Guangdong Biolight Meditech by Region, 2009-2013
Gross Margin of Guangdong Biolight Meditech, 2009-2013 
Gross Margin of Guangdong Biolight Meditech by Product, 2009-2013
Gross Margin of Guangdong Biolight Meditech by Region, 2009-2013
R&D Input and % of Total Revenue of Guangdong Biolight Meditech, 2010-2013
Revenue and Net Income of Guangdong Biolight Meditech, 2012-2016E
Revenue and Net Income of Mindray Medical International Limited, 2009-2013 
Revenue Structure of Mindray Medical International Limited by Product, 2009-2013
Revenue Structure of Mindray Medical International Limited by Region, 2009-2013
Gross Margin of Mindray Medical International Limited, 2009-2013 
R&D Input and % of Total Revenue of Mindray Medical International Limited, 2009-2013
Revenue and Net Income of Mindray Medical International Limited, 2012-2016E
Revenue and Net Income of Edan Instruments, 2009-2013 
Revenue Structure of Edan Instruments by Product, 2009-2013
Revenue Structure of Edan Instruments by Region, 2009-2013
Gross Margin of Edan Instruments, 2009-2013
Gross Margin of Edan Instruments by Product, 2009-2013 
R&D Input and % of Total Revenue of Edan Instruments, 2011-2013
Revenue and Net Income of Edan Instruments, 2012-2016E
China Portable Medical Device Market Size, 2012-2016E
Revenue of China’s Leading Portable Medical Device Enterprises, 2009-2013 
YoY Revenue Growth of China’s Leading Portable Medical Device Enterprises, 2010-2013 
Net Profit Margin of China’s Leading Portable Medical Device Enterprises, 2009-2013
Gross Margin of China’s Leading Portable Medical Device Enterprises, 2009-2013
R&D Input of China’s Leading Portable Medical Device Enterprises, 2010-2013
R&D Input and % of Total Revenue of China’s Leading Portable Medical Device Enterprises, 2010-2013

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号